Abstract: This paper proposes an improved backstepping-based trajectory tracking control strategy for autonomous vehicles (AVs). Unlike traditional backstepping control, the proposed method ...

Abstract: This article addresses the problem of poor dynamic performance of conventional virtual synchronous generators (VSGs) when switched to grid-connected mode (GCM) due to varying grid conditions ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc has faced significant challenges in its financial performance, highlighted by a sharp decline in revenue growth, which fell to -32.98% in Q3 2025 from +30.14% in Q2 2025.

Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

This repository contains a C++ library that implements an invariant extended Kalman filter (InEKF) for 3D aided inertial navigation. This filter can be used to estimate a robot's 3D pose and velocity ...